Navigation Links
Massive microRNA scan uncovers leads to treating muscle degeneration
Date:10/17/2007

Researchers have discovered the first microRNAs tiny bits of code that regulate gene activity linked to each of 10 major degenerative muscular disorders, opening doors to new treatments and a better biological understanding of these debilitating, poorly understood, often untreatable diseases. The study, to be published online this week by the Proceedings of the National Academy of Sciences, was led by Iris Eisenberg, PhD, of the Program in Genomics at Childrens Hospital Boston. Louis Kunkel, PhD, director of the Program in Genomics and an investigator with the Howard Hughes Medical Institute, was senior investigator.

The disorders include the muscular dystrophies (Duchenne muscular dystrophy, Becker muscular dystrophy, limb girdle muscular dystrophies, Miyoshi myopathy, and fascioscapulohumeral muscular dystrophy); the congenital myopathies (nemaline myopathy); and the inflammatory myopathies (polymyositis, dermatomyositis, and inclusion body myositis). While past studies have linked them with an increasing number of genes, it's still largely unknown how these genes cause muscle weakness and wasting, and, more importantly, how to translate the discoveries into treatments.

For instance, most muscular dystrophies begin with a known mutation in a master gene, leading to damaged or absent proteins in muscle cells. In Duchenne and Becker muscular dystrophies, the absent protein is dystrophin, as Kunkel himself discovered in 1987. Its absence causes muscle tissue to weaken and rupture, and the tissue becomes progressively nonfunctional through inflammatory attacks and other damaging events that arent fully understood.

The initial mutations do not explain why patients are losing their muscle so fast, says Eisenberg. There are still many unknown genes involved in these processes, as well as in the inflammatory processes taking place in the damaged muscle tissue.

She and Kunkel believe microRNAs may help provide the missing
'/>"/>

Contact: James Newton
james.newton@childrens.harvard.edu
617-919-3110
Children's Hospital Boston
Source:Eurekalert

Page: 1 2

Related biology news :

1. New plant DNA libraries provides massive boost to worlds plant researchers
2. Underlying cause of massive pinyon pine die-off revealed
3. Massive duplication of genes may solve Darwins abominable mystery about flowering plants
4. PNAS study reveals why organs fail following massive trauma
5. Massive coral death attributed to earthquake
6. Massive herds of animals found to still exist in Southern Sudan
7. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
8. Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression
9. NYU, Rockefeller researchers find complexity of regulation by microRNA genes
10. MicroRNAs play a big part in gene regulation - and evolution
11. Molecular steps involved in the creation of gene-silencing microRNAs identified

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... Using highly precise measurements of plasma lipop...ic resonance spectroscopy (NMR), researchers led b...nd Harvard Medical School in Boston, MA, the Frami... consortium in Stockholm, Sweden and Oxford, Engla...he whole genome among 17,296 women of European anc...
(Date:11/20/2009)... Researchers are invited to contribute their abstr...OF WCO ECCEO10), the largest global meeting devot...is research and patient care. The Congress will be...eginning today, abstracts can be submitted online ...sion deadline is February 4, 2010. , IOF and ESC...
(Date:11/20/2009)..., A key question in the origin of biological mol...ether billions of years ago from simple precursors...searchers in Italy have reconstructed one of the e...ains of RNA from individual subunits using nothing...t RNA was one of the first biological molecules pr...
Breaking Biology News(10 mins):Genetic analysis helps dissect molecular basis of cardiovascular disease 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 1National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 2National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 3National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 4Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies 13255 1Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies 13255 2Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies 13255 3Stryker Announces Election of New Director 53107 1Stryker Announces Election of New Director 53107 2
...uebec City, Canada - An international team of scie...iversity of Hull, Cardiff University) and Spain (D...pair of closely related species of East African ci...rising hundreds of species has puzzled evolutionar... gene adaptations which might explain why they do ...
...AINESVILLE, Fla. When the first four-legged animal...genetic recipe and simply extended the cooking tim... Wednesdays issue of the journal PLoS ONE. , Ev... billion years have the recipe for fingers in thei...hem. , While studying the mechanisms of developm...
...OSTONColon cancer patients who eat a diet high in ...erts a so-called Western diet may be increasing ...eport researchers at Dana-Farber Cancer Institute....he Journal of the American Medical Association, in...that has been treated with both surgery and chemot...
Other Biology News:Adaptation to parasites drive African fishes along different evolutionary paths 2Conquest of land began in shark genome 2Conquest of land began in shark genome 3'Western' diet linked to increased risk of colon cancer recurrence 2
(Date:11/19/2009)...Nov. 19 Dr. Mate Hidvegi, inventor...to a press release issued on November 17 by Biroph...aking false and self-serving statements about its ...idvegi stated from his office in Budapest, Hungary...emar does not apply to AveULTRA, www.aveultra.co...
(Date:11/19/2009)...9 NeoStem, Inc. (NYSE Am...ollowing letter to its shareholders, discussing th...hina Biopharmaceuticals Holdings, Inc. (CHBP), an ... People,s Republic of China. The merger gives NeoS...maceutical Co. Ltd., CHBP,s primary operating subs...
(Date:11/19/2009)... and WALTHAM, Mass., Nov. 19 Arlin...s find that the leading driver of antibiotic selec...ectrum activity against gram-positive and gram-neg...hat can cause nosocomial pneumonia, surveyed Europ... agents that provide appropriate coverage against ...
(Date:11/19/2009)...9 /PRNewswire/ - Aegera Therapeutics Inc. announce...mized Phase 2B study of AEG35156, a targeted antis...iple oncology indications. ,, The study, entitl...X-Linked Inhibitor of Apoptosis (XIAP) Antisense A...bine and Idarubicin in AML Following Failure of a ...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
... May 11 Pharmasset, Inc. (Nasdaq: VRUS ), a cli...scovering, developing, and commercializing novel d... results and operational highlights for the fiscal...sults , , Revenues were $1.9 million during the ...ion for the quarter ended March 31, 2008 and refle...
...1, 2009 Arena Pharmaceuticals, Inc. (Nasdaq: AR...t quarter ended March 31, 2009. , , Arena report...the first quarter of 2009 of $50.6 million, or $0....common stockholders in the first quarter of 2008 o...ing the positive lorcaserin BLOOM results was a si...
... joins the Digital Arts Alliance , , BATON ROUGE,...ed plans to support, for the second year in a row,...nsive Orientation for Students (BIOS) program with... class of Pearson Foundation Digital Arts Fellows ...es and pass them along to future program participa...
Other Biology Technology:Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 2Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 3Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 4Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 5Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 6Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 7Pharmasset Reports Fiscal Second Quarter 2009 Financial Results 8Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 2Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 3Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 4Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 5Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 6Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 7Arena Pharmaceuticals Announces First Quarter 2009 Financial Results 8Pearson Foundation Supports Incoming LSU Biology Students With 21st Century Learning Tools 2Pearson Foundation Supports Incoming LSU Biology Students With 21st Century Learning Tools 3
CLEARMOUNT from Invitrogen
...Polyclonal Antibody Production Conjugated pepti...abbits ten-week protocol to produce antibodies in...00-120 ml antiserum) ELISA test until the titer r...eaches target titer Protein G purification Antib...
3' RACE Adapter Primer from Invitrogen
Normal Goat Serum from Calbiochem
Biology Products: